Alumis

Alumis is a biotechnology company headquartered in South San Francisco, California. The company employs 155 individuals. Alumis is focused on developing targeted therapies for immune-mediated diseases, aiming to provide alternatives to broad immunosuppression. They leverage data analytics to identify the most effective targets, molecules, and patient populations for their therapies, with the goal of optimizing patient outcomes. Alumis's precision approach to drug development seeks to deliver the next generation of treatments for immune dysfunction. Incubated by Foresite Labs, the company is driven by a team of experienced professionals dedicated to improving the lives of patients with immune-mediated diseases. Interested parties can visit Alumis's website at alumis.com for further information.